Home/Filings/4/0001019056-23-000335
4//SEC Filing

Shaker Benjamin 4

Accession 0001019056-23-000335

CIK 0001831097other

Filed

Aug 15, 8:00 PM ET

Accepted

Aug 16, 4:17 PM ET

Size

14.9 KB

Accession

0001019056-23-000335

Insider Transaction Report

Form 4
Period: 2023-08-14
Shaker Benjamin
Chief Markets Officer
Transactions
  • Exercise/Conversion

    Options (Right to buy)

    2023-08-1418,750358,101 total
    Exercise: $3.79Exp: 2029-02-09Common Stock (18,750 underlying)
  • Exercise/Conversion

    Common Stock

    2023-08-15$3.79/sh+18,750$71,06398,293 total
  • Exercise/Conversion

    Options (Right to buy)

    2023-08-1518,750339,351 total
    Exercise: $3.79Exp: 2029-02-09Common Stock (18,750 underlying)
  • Sale

    Common Stock

    2023-08-14$18.72/sh18,750$351,08379,543 total
  • Sale

    Common Stock

    2023-08-15$18.10/sh18,750$339,30979,543 total
  • Exercise/Conversion

    Common Stock

    2023-08-14$3.79/sh+18,750$71,06398,293 total
Footnotes (5)
  • [F1]Includes restricted stock units.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $18.42 to $19.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.865 to $18.360, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F5]These options were granted on February 9, 2019, and became fully vested as of February 9, 2023.

Documents

1 file

Issuer

agilon health, inc.

CIK 0001831097

Entity typeother

Related Parties

1
  • filerCIK 0001855843

Filing Metadata

Form type
4
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:17 PM ET
Size
14.9 KB